GlassScriptPhysician profile
Caitlin Deakin
NPI 1225484686
$1,187.11
in general payments reported to CMS, 2019-2025
20 companies · $19.44 in 2025
The $19.44 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.26 · 2021: $337 · 2022: $416 · 2023: $304 · 2024: $76.93 · 2025: $19.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $299.13 | 2021-2022 | |
| Abbvie INC. | $157.42 | 2022-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Daiichi Sankyo INC. | $139.54 | 2021-2022 | |
| Aspira Women'S Health INC | $76.81 | 2022-2024 | Ova1 |
| Therapeuticsmd, INC. | $70.15 | 2020-2021 | |
| Coopersurgical, INC. | $62.91 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $58.93 | 2022-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $55.41 | 2022-2023 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Mayne Pharma Commercial LLC | $41.39 | 2022 | |
| Merck Sharp & Dohme LLC | $39.43 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $27.31 | 2023 | Myfembree |
| Biogen, INC. | $22.47 | 2024 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $22.06 | 2023 | |
| Becton, Dickinson and Company | $21.17 | 2021 | |
| Millicent US INC | $19.44 | 2025 | Femring, Intrarosa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $19.06 | 2022 | |
| Minerva Surgical, INC | $16.97 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $15.58 | 2022 | |
| Olympus America INC. | $13.71 | 2022 | |
| Meditrina | $8.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Deakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.